Edition:
United States

Profile: Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

2.45DKK
10:54am EDT
Change (% chg)

kr.-0.02 (-0.81%)
Prev Close
kr.2.47
Open
kr.2.36
Day's High
kr.2.47
Day's Low
kr.2.36
Volume
99,419
Avg. Vol
30,315
52-wk High
kr.3.10
52-wk Low
kr.2.20

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous system (CNS) diseases and acts as a dopaminergic stabilizer; and Ordopidine, a medicine, which also is involved in the CNS disease treatment as a dopaminergic stabilizer. Furthermore, the Company operates through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S, as well as through affiliates, such as Atonomics A/S and NsGene A/S.

Company Address

Neurosearch A/S

Strandvejen 60
HELLERUP     2900
P: +4544.608000
F: +4544.608080

Company Web Links